Return to study ST001365 main page

MB Sample ID: SA099252

Local Sample ID:Sample_15137
Subject ID:SU001439
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Age Or Age Range:21-56
Gender:Male and female
Human Inclusion Criteria:Cystic Fibrosis, adults

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU001439
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Age Or Age Range:21-56
Gender:Male and female
Human Inclusion Criteria:Cystic Fibrosis, adults

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
Sample_15137SA099252FL014053CF_sampleFactor

Collection:

Collection ID:CO001434
Collection Summary:Sputum samples from 11 subjects with cystic fibrosis were selected from a larger airway microbiome study that was approved by the University of Michigan Medical School Institutional Review Board. Subjects were 6 males and 5 females, age 21 to 56 years (median 37). Sputum samples were collected by subjects at home and stored at 4˚C for up to 23 days and then transferred to -80˚C.
Sample Type:Sputum
Storage Conditions:Described in summary

Treatment:

Treatment ID:TR001454
Treatment Summary:The goal of this study was to determine which antibiotics are present in cystic fibrosis sputum using a LC-MS method. There were no experimental conditions. The types of samples included in the LC-MS run were: cystic fibrosis sputum, external standard curve, quality control pools of external standards run every ~50 samples, and washes (blanks).

Sample Preparation:

Sampleprep ID:SP001447
Sampleprep Summary:The extraction solvent was chilled 1% DTT and spiked with 1.33 µM of both internal standards, linezolid-d3 and levofloxacin-d8. Solvent (150 µL) was added to 50 µL of sputum. The samples were vortexed for 30 seconds, shaken at 4˚C on a shaking platform with moderate agitation for 15 minutes, and centrifuged at 13,200 RCF for 10 minutes at 4˚C. The supernatant was pipetted into amber glass vials and injected directly into the LC-MS.
Processing Storage Conditions:On ice
Extract Storage:On ice

Combined analysis:

Analysis ID AN002272
Analysis type MS
Chromatography type Reversed phase
Chromatography system Waters Acquity I-Class
Column Waters Acquity BEH C18 (50 x 2.1mm,1.7um)
MS Type ESI
MS instrument type Triple quadrupole
MS instrument name Waters Quattro Premier XE
Ion Mode POSITIVE
Units micromolar

Chromatography:

Chromatography ID:CH001671
Methods Filename:qopt_A2B2_3g_c9_5min.wvhp
Instrument Name:Waters Acquity I-Class
Column Name:Waters Acquity BEH C18 (50 x 2.1mm,1.7um)
Column Temperature:50
Flow Rate:0.3 ml/min
Injection Temperature:10
Solvent A:100% water; 0.1% acetic acid; 10 mM ammonium acetate
Solvent B:100% methanol; 0.1% formic acid; 2 mM ammonium acetate
Chromatography Type:Reversed phase

MS:

MS ID:MS002116
Analysis ID:AN002272
Instrument Name:Waters Quattro Premier XE
Instrument Type:Triple quadrupole
MS Type:ESI
MS Comments:The retention times (RT) and MS/MS parameters for reach antibiotic were determined using the QuanOpt function in the Waters Masslynx software. Peaks were automatically picked and filtered in QuanLynx. Downstream filtering was conducted in R. Data were imported into R and the following criteria for filtering were applied: minimum peak area under the curve of 20 and signal to noise ratio of 10. Because several of the antibiotics had high carry-over rates (including ciprofloxacin, levofloxacin, and trimethoprim), sample peaks were also filtered out when the AUC was lower than the wash ran directly before the sample. Scripts can be found at the following github link: https://github.com/tgallagh/LCMS_Antibiotics.
Ion Mode:POSITIVE
Capillary Voltage:3.3 kV
Collision Gas:Nitrogen
Source Temperature:125
Desolvation Gas Flow:800 L/h
Desolvation Temperature:400
Acquisition Parameters File:CF_antibiotics.exp
Analysis Protocol File:CF_antibiotics_quant.mdb
  logo